The cardiovascular effects of an intravenous infusion of adrenaline (Io jig./min.) and isoprenaline (o075 jig./min.) have been compared in two groups of six patients in the early post-operative period following aortic valvar homograft replacement. These doses were chosen to produce obvious haemodynamic effects without precipitating dysrhythmias. Though both drugs have been shown to improve the circulatory state, adrenaline caused a greater change in stroke volume and in arterial pulse pressure, and for any given rise in heart rate a greater increase in the cardiac index. In addition, adrenaline caused a greater improvement in the relation between oxygen demand and oxygen supply of the body. Isoprenaline did not cause an increase in systolic and pulse pressure and always aggravated hypoxaemia. It is concluded from this study that adrenaline is the more satisfactory drug to use in the early post-operative phase following aortic valvar homograft replacement.
The haemodynamic effects of intravenous adrenaline and isoprenaline have been studied in normal subjects (Gorten et al., I96I; Weissler, Leonard, and Warren, 1959; Harrison et al., I964; Allwood et al., I962; Barcroft and Starr, 195I; Cyvin et al., 1955; Goldberg et al., I960;  Dodge, Lord, and Sandler, I960) and in diseased states (Bruce et al., I96I; Benchimol, Lucena, and Dimond, I965; COX, Cobb, and Bruce, I963; Witham and Fleming, I95I), including congestive heart failure (Dodge et al., I960; Dodge and Murdaugh, I957). The results of these studies have been used to predict the haemodynamic changes that will follow their administration when used to treat low cardiac output states in the post-operative period after open-heart surgery (Moffitt, Sessler, and Kirklin, I967) .
In this paper we wish to document the cardiovascular effects during an intravenous infusion of adrenaline and isoprenaline after aortic valvar homograft replacement and to compare the effects of the two drugs in detail to determine which is preferable in the postoperative period.
Subjects and methods Twelve patients were studied I6 to 20 hours after aortic valvar homograft replacement, 6 of whom were given intravenous isoprenaline and 6 intravenous adrenaline. The clinical details of the patients studied are listed in Table i (Resnekov, Fordham, and Ross, 1968; Fordham, Resnekov, and Paddle, I968) . In brief, the following measurements were made before and during the drug infusion: oxygen consumption, arterial (ascending aorta) and mixed venous blood oxygen content (pulmonary artery), heart rate, systemic arterial, pulmonary arterial, and right atrial pressures. The arteriovenous oxygen difference, cardiac output (Fick principle), left ventricular stroke work, left ventricular minute work, and their indices, and the total peripheral resistance were calculated from the measurements as listed using standard formulae. The effects of an infusion of adrenaline (io jtg./min.) and isoprenaline (o075 t,g./min.) were compared after IO minutes of administration of each drug and while the infusion continued, and the results were analysed for statistical significance using the Student's 't' test (Bradford Hill, I966) .
Results
The mean control values, mean values during infusions of isoprenaline and adrenaline, and the mean changes in the measured and calculated parameters for each drug, as well as their statistical significance, are shown in Table 2 . The changes from the control values during the infusion of the two drugs are compared in Fig. i , in which the statistical significance of the differences between the effects of the two drugs is also given.
Despite the small numbers of the patients in each group, a statistically significant difference (p < ooi) was found between the two drugs for changes in the stroke index (isoprenaline + I.0 ml./m.2, adrenaline + 5.5 ml./m.2) and arterial pulse pressure (isoprenaline + 3 mm. Hg, adrenaline + 3I mm. Hg). Probable significant differences (p < o.os) were found for mean changes in arterial systolic pressure (isoprenaline +3 mm. Hg, adrenaline + 30 mm. Hg), total peripheral resistance (isoprenaline -223 dynes sec. cm. 5, adrenaline -572 dynes sec. cm. 5) and left ventricular stroke work index (isoprenaline + 2-4 g.m./m.2, adrenaline + 8-9 g.m./m2). Variable increases were found in the heart rate in the two groups, though during infusionof isoprenaline the increase in heart rate was found to be inversely related to the control value (Resnekov et al., I968), a relation that did not occur during the infusion of adrenaline. The mean heart rate increase was slightly greater during infusion of isoprenaline (+ i9 beats/min.), than during infusion of adrenaline (+ I3 beats/min.) at the doses employed. Greater mean changes in cardiac index, oxygen (Table 2 ), but the difference between the effects of the two drugs failed to achieve statistical significance (Fig. i) effects on stroke volume. Individual changes in cardiac index plotted against changes in heart rate are shown in Fig. 2 . As can be seen, for any given rise in heart rate there was generally a greater increase in cardiac index produced by adrenaline than by isoprenaline (except for Case 12). This finding is explained by the increase in stroke index induced by adrenaline, but not by isoprenaline. We have previously shown that a given dose of isoprenaline will produce a larger rise in heart rate and cardiac index when the control heart rate is slow than when it is rapid (Resnekov et al., I968), whereas no such relation was found with adrenaline. Furthermore, adrenaline seems the more effective drug in increasing the cardiac output when reduced. This is especially true when the control heart rate is high and the cardiac output low; a satisfactory increase in cardiac output may require higher doses of isoprenaline than used in this study and precipitate dysrhythmias.
The greater increase in cardiac output for a given rise in heart rate produced by adrenaline is reflected in the changes in the arteriovenous oxygen difference. From Fig. 3a it can be seen that, when compared to changes in heart rate, adrenaline produces a greater fall in arteriovenous oxygen difference than does isoprenaline, and that the magnitude of this fall is related to the change in cardiac index (Fig. 3b) , irrespective of the drug used. Since the arteriovenous oxygen difference is an index of the relation between supply and A H.R. demand of oxygen in the tissues, adrenaline causes a greater improvement in oxygen supply to the body, in relation to demand, for any given increase in heart rate.
Differences were found in the effects of the two drugs on brachial artery systolic and pulse pressures (Fig. 4) . Adrenaline caused a rise in these parameters, with no associated changes in diastolic or mean pressures. No consistent changes were caused by isoprenaline. In Fig. 4 it can be seen that increases in pulse pressure are linearly related to increases in stroke index, which suggests that the absence of any change in pulse pressure during isoprenaline infusion is secondary to its lack of effect on the stroke volume.
The relation between changes in total peripheral resistance and changes in heart (a) (b) rate are shown in Fig. 5a . For a given change in heart rate a greater fall in total peripheral resistance occurs with adrenaline, though no difference between the two drugs was shown when changes in total peripheral resistance were compared with changes in cardiac output (Fig. 5b) .
From the data we have obtained, adrenaline appears to be the more effective drug in raising the stroke volume, cardiac output, and brachial arterial systolic and pulse pressures, and in reducing the arteriovenous oxygen difference and total peripheral resistance, especially when these changes are related to increases in heart rate. One disadvantage of isoprenaline was found, namely, it consistently aggravated arterial hypoxaemia (Fordham and Resnekov, I968) . From the information obtained in this study, therefore, adrenaline appears to be preferable to isoprenaline in the treatment of low cardiac output states after aortic valvar replacement.
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